Synthesis and biological activity of 3-N-substituted estrogen derivatives as breast cancer agents

Area of Science:

• Medicinal Chemistry
• Oncology
• Pharmacology

Background:

• Estrogen derivatives are investigated for their potential in cancer therapy.
• Understanding structure-activity relationships is crucial for developing novel anticancer agents.
• Hormone receptor-positive and negative cancer cell lines provide models for drug screening.

Purpose of the Study:

• To synthesize and characterize novel 3-N-substituted estrogen derivatives.
• To evaluate the antiproliferative activity of these derivatives against human breast and endometrial cancer cell lines.
• To compare the efficacy of novel compounds with established drugs like tamoxifen.

Main Methods:

• Synthesis and characterization of 3-N-substituted estrogen derivatives.
• In vitro antiproliferative assays using CellTiter-Glo on MCF-7, MDA-MB-231, and Ishikawa cell lines.
• Determination of half-maximal inhibitory concentration (IC50) values after 72-hour drug exposure.

Main Results:

• Compound 5 showed antiproliferative activity against MDA-MB-231 cells (IC50 = 12 µM).
• Compounds 6, 7, and 13 exhibited enhanced activity against MCF-7 and Ishikawa cells (IC50 = 12 µM) compared to tamoxifen (19-33 µM).
• The novel derivatives were assessed across a wide concentration range (0.01-100,000 nM).

Conclusions:

• The synthesized 3-N-substituted estrogen derivatives possess significant antiproliferative properties.
• Compounds 6, 7, and 13 represent promising candidates for further investigation in breast and endometrial cancer treatment.
• These findings contribute to the development of novel therapeutic strategies targeting estrogen-dependent and independent cancers.